Keywords: merck, kgaa, accepts, mylan, bilion-euro, offer, its

Merck KGaA accepts Mylan's 4.9 bilion-euro offer for its generics business

Article | 21 May 2007

US generic drugmaker Mylan Laboratories has beaten off competition from the likes of Israeli firm Teva Pharmaceutical Industries, Germany's Stada ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in